Rituximab went off patent in the US last year, leaving it open to competition

[Pete]

It does, but it is an awfully unfair expense for the taxpayers. Unless it works wonders, I won't continue it.

Hey, the bozos in Washington are an unfair expense to the taxpayers too!! Just sayin'...